Eledon Pharmaceuticals, Inc. (ELDN)
2.99
-0.02
(-0.66%)
USD |
NASDAQ |
Sep 02, 16:00
2.985
0.00 (0.00%)
After-Hours: 20:00
Eledon Pharmaceuticals Cash and Short Term Investments (Quarterly) : 88.76M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 88.76M |
| March 31, 2026 | 111.09M |
| December 31, 2025 | 133.34M |
| September 30, 2025 | 93.40M |
| June 30, 2025 | 107.57M |
| March 31, 2025 | 124.88M |
| December 31, 2024 | 140.18M |
| September 30, 2024 | 78.19M |
| June 30, 2024 | 83.61M |
| March 31, 2024 | 42.86M |
| December 31, 2023 | 51.10M |
| September 30, 2023 | 59.61M |
| June 30, 2023 | 71.38M |
| March 31, 2023 | 46.48M |
| December 31, 2022 | 56.41M |
| September 30, 2022 | 65.89M |
| June 30, 2022 | 70.46M |
| March 31, 2022 | 76.68M |
| December 31, 2021 | 84.83M |
| September 30, 2021 | 94.04M |
| June 30, 2021 | 101.13M |
| March 31, 2021 | 108.58M |
| December 31, 2020 | 114.20M |
| September 30, 2020 | 114.46M |
| June 30, 2020 | 8.764M |
| Date | Value |
|---|---|
| March 31, 2020 | 11.78M |
| December 31, 2019 | 8.791M |
| September 30, 2019 | 10.81M |
| June 30, 2019 | 13.70M |
| March 31, 2019 | 9.056M |
| December 31, 2018 | 12.97M |
| September 30, 2018 | 16.32M |
| June 30, 2018 | 19.19M |
| March 31, 2018 | 22.52M |
| December 31, 2017 | 17.30M |
| September 30, 2017 | 19.09M |
| June 30, 2017 | 22.51M |
| March 31, 2017 | 24.40M |
| December 31, 2016 | 1.117M |
| September 30, 2016 | 34.72M |
| June 30, 2016 | 43.93M |
| March 31, 2016 | 54.25M |
| December 31, 2015 | 63.96M |
| September 30, 2015 | 73.10M |
| June 30, 2015 | 83.19M |
| March 31, 2015 | 94.16M |
| December 31, 2014 | 105.26M |
| September 30, 2014 | 105.46M |
| June 30, 2014 | 21.15M |
| March 31, 2014 | 27.01M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 7.863B |
| Viking Therapeutics, Inc. | 501.66M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |